Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

5.00%

8.4¢ percheron therapeutics limited

For General Information, page-469

First 469 Last

Share
Profile

Follow
Ressy

31 Posts.

36

25/05/22

15:34

Post #: 61616308
Share

Originally posted by BoomCrashOffera: ↑

I thought that $74 mill to fund the pivotal trial and cover G&A for the duration seemed a steep number for 108-114 trial patients. In looking at the application of funds back in the CR presentation, I noticed that drug manufacture was estimated to cost $7.4 mill to futility, which is effectively the half way point (I assume Ionis are the manufacturer). Let’s assume that drug manufacture for the entire trial costs twice this, which is $14.8 mill. Only two thirds of the trial patients (72-76) are receiving ATL1102 (one third receive placebo/SOC only). That means, the annual cost per patient in the trial comes to approximately $200,000 or $4,000 per weekly jab. As this is the revenue per year estimated per patient once commercialised (used when they calculated their $4 bill TAM), I hope we can manufacture at a much reduced cost, assuming commercialisation success, to extract SOME margin. Secondly, why do Ionis get to charge this figure pre-commercialisation and 3 years after their ATL1102 patents have expired?

Expand

Ionis is not the manufacturer. There's an announcement on the 26 May 2021 that details this information.

ANP Price at posting: 9.9¢ Sentiment: None Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

SUM

Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation

MBK

Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

DRE

Dreadnought hits thick intercepts of 1.3% niobium at WA's Gifford Creek

Bitcoin: Current State of Play & Where to Next | Swyftx

There are more pages in this discussion • 3,058 more messages in this thread...

First 469 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change 0.004(5.00%)		Mkt cap ! $75.72M

Open	High	Low	Value	Volume
8.3¢	8.4¢	8.3¢	$3.72K	44.45K

Buyers (Bids)

No.	Vol.	Price($)
1	32573	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	50328	2

View Market Depth

No.	Vol.	Price($)
1	32573	0.082
4	104839	0.081
2	127624	0.080
1	10000	0.077
4	186800	0.075

Price($)	Vol.	No.
0.084	50328	2
0.085	363000	2
0.086	480000	3
0.087	400000	1
0.088	406000	2

Last trade - 10.30am 19/08/2024 (20 minute delay)

PER (ASX) Chart